{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:46:22Z","timestamp":1771274782536,"version":"3.50.1"},"reference-count":87,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Flavonoids express a wide range of medicinal properties, our study presented\nresults on the anticancer activity of selected compounds using in silico studies.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>In this article, in silico studies were carried out to find promising anticancer lead among\nselected flavonoid compounds.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Here, we carried out molecular docking and MD simulation for anticancer screening of\nflavonoid derivatives against CDK2 and CDK9 proteins.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Among the compounds under investigation, Flavone and Recoflavone had the lowest binding\nenergy against CDK2\/CDK9 targets using docking studies and MD simulations.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>We can conclude that Flavone and Recoflavone are promising anticancer lead compounds\nin the development of new anticancer drugs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115734064314933240812120123","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T08:08:01Z","timestamp":1724918881000},"page":"69-83","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Docking and Molecular Dynamics Studies on Anticancer Activities of Flavonoids as Inhibitors of CDK2 and CDK9"],"prefix":"10.2174","volume":"21","author":[{"given":"A.S.","family":"Sony","sequence":"first","affiliation":[{"name":"Department of Chemistry, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Xavier","family":"Suresh","sequence":"additional","affiliation":[{"name":"School of Advanced Sciences and Languages, VIT Bhopal University, Madhya Pradesh, 466114, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bmc.2019.01.027","volume":"27","author":"Zhao L.","year":"2019","unstructured":"Zhao L.; Yuan X.; Wang J.; Feng Y.; Ji F.; Li Z.; Bian J.; A review on flavones targeting serine\/threonine protein kinases for potential anticancer drugs. Bioorg Med Chem  2019,27(5),677-685","journal-title":"Bioorg Med Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1017\/jns.2016.41","volume":"5","author":"Panche A.N.","year":"2016","unstructured":"Panche A.N.; Diwan A.D.; Chandra S.R.; Flavonoids: An overview. J Nutr Sci  2016,5,e47","journal-title":"J Nutr Sci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.3390\/cancers13194989","volume":"13","author":"Nkwe D.O.","year":"2021","unstructured":"Nkwe D.O.; Lotshwao B.; Rantong G.; Matshwele J.; Kwape T.E.; Masisi K.; Gaobotse G.; Hefferon K.; Makhzoum A.; Anticancer mechanisms of bioactive compounds from solanaceae: An update. Cancers  2021,13(19),4989","journal-title":"Cancers"},{"key":"ref=4","first-page":"284","volume":"17","author":"Erdman J.W.","year":"2008","unstructured":"Erdman J.W.; Carson L.; Kwik-Uribe C.; Evans E.M.; Allen R.R.; Allen R.R.; Rd M.; Effects of cocoa flavanols on risk factors for cardiovascular disease. Asia Pac J Clin Nutr  2008,17(S1)(Suppl. 1),284-287","journal-title":"Asia Pac J Clin Nutr"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/gb4184","volume":"15","author":"Malumbres M.","year":"2014","unstructured":"Malumbres M.; Cyclin-dependent kinases. Genome Biol  2014,15(6),122","journal-title":"Genome Biol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"Malumbres M.","year":"2009","unstructured":"Malumbres M.; Barbacid M.; Cell cycle, CDKs and cancer: A changing paradigm. Nat Rev Cancer  2009,9(3),153-166","journal-title":"Nat Rev Cancer"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00432-011-1039-4","volume":"137","author":"Cicenas J.","year":"2011","unstructured":"Cicenas J.; Valius M.; The CDK inhibitors in cancer research and therapy. J Cancer Res Clin Oncol  2011,137(10),1409-1418","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/374131a0","volume":"374","author":"Morgan D.O.","year":"1995","unstructured":"Morgan D.O.; Principles of CDK regulation. Nature  1995,374(6518),131-134","journal-title":"Nature"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e1816","DOI":"10.1002\/wrna.1816","volume":"15","author":"Pluta A.J.","year":"2024","unstructured":"Pluta A.J.; Studniarek C.; Murphy S.; Norbury C.J.; Cyclindependent kinases: Masters of the eukaryotic universe. Wiley Interdiscip Rev RNA  2024,15(1),e1816","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3390\/ijms21061960","volume":"21","author":"Ding L.","year":"2020","unstructured":"Ding L.; Cao J.; Lin W.; Chen H.; Xiong X.; Ao H.; Yu M.; Lin J.; Cui Q.; The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer. Int J Mol Sci  2020,21(6),1960","journal-title":"Int J Mol Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4615-5371-7_8","volume":"3","author":"Peter M.","year":"1997","unstructured":"Peter M.; The regulation of cyclin-dependent kinase inhibitors (CKIs). Prog Cell Cycle Res  1997,3,99-108","journal-title":"Prog Cell Cycle Res"},{"key":"ref=12","author":"Al Aboud N.M.","year":"2023","unstructured":"Al Aboud N.M.; Tupper C.; Jialal I.;  Genetics, Epigenetic Mechanism  2023","journal-title":"Genetics, Epigenetic Mechanism"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"35728","DOI":"10.1074\/jbc.M110.154005","volume":"285","author":"Marais A.","year":"2010","unstructured":"Marais A.; Ji Z.; Child E.S.; Krause E.; Mann D.J.; Sharrocks A.D.; Cell cycle-dependent regulation of the forkhead transcription factor FOXK2 by CDK\u00b7cyclin complexes. J Biol Chem  2010,285(46),35728-35739","journal-title":"J Biol Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1038\/s41467-019-13105-5","volume":"10","author":"Nie L.","year":"2019","unstructured":"Nie L.; Wei Y.; Zhang F.; Hsu Y.H.; Chan L.C.; Xia W.; Ke B.; Zhu C.; Deng R.; Tang J.; Yao J.; Chu Y.Y.; Zhao X.; Han Y.; Hou J.; Huo L.; Ko H.W.; Lin W.C.; Yamaguchi H.; Hsu J.M.; Yang Y.; Pan D.N.; Hsu J.L.; Kleer C.G.; Davidson N.E.; Hortobagyi G.N.; Hung M.C.; CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer. Nat Commun  2019,10(1),5114","journal-title":"Nat Commun"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12964-018-0267-5","volume":"16","author":"Zhang X.","year":"2018","unstructured":"Zhang X.; Zhao Y.; Wang C.; Ju H.; Liu W.; Zhang X.; Miao S.; Wang L.; Sun Q.; Song W.; Rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-Akt and CDK2 levels. Cell Commun Signal  2018,16(1),65","journal-title":"Cell Commun Signal"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.molcel.2006.06.014","volume":"23","author":"Peterlin B.M.","year":"2006","unstructured":"Peterlin B.M.; Price D.H.; Controlling the elongation phase of transcription with P-TEFb. Mol Cell  2006,23(3),297-305","journal-title":"Mol Cell"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6945129","volume":"2018","author":"Schlafstein A.J.","year":"2018","unstructured":"Schlafstein A.J.; Withers A.E.; Rudra S.; Danelia D.; Switchenko J.M.; Mister D.; Harari S.; Zhang H.; Daddacha W.; Ehdaivand S.; Li X.; Torres M.A.; Yu D.S.; CDK9 expression shows role as a potential prognostic biomarker in breast cancer patients who fail to achieve pathologic complete response after neoadjuvant chemotherapy. Int J Breast Cancer  2018,2018,1-9","journal-title":"Int J Breast Cancer"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10549-019-05365-y","volume":"178","author":"Del Re M.","year":"2019","unstructured":"Del Re M.; Bertolini I.; Crucitta S.; Fontanelli L.; Rofi E.; De Angelis C.; Diodati L.; Cavallero D.; Gianfilippo G.; Salvadori B.; Fogli S.; Falcone A.; Scatena C.; Naccarato A.G.; Roncella M.; Ghilli M.; Morganti R.; Fontana A.; Danesi R.; Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4\/6 inhibitors in metastatic breast cancer patients. Breast Cancer Res Treat  2019,178(1),57-62","journal-title":"Breast Cancer Res Treat"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2022.2126397","author":"Biharee A.","year":"2022","unstructured":"Biharee A.; Yadav A.; Jangid K.; Singh Y.; Kulkarni S.; Sawant D.M.; Kumar P.; Thareja S.; Jain A.K.; Flavonoids as promising anticancer agents: An in silico investigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations. J Biomol Struct Dyn  2022,1-12","journal-title":"J Biomol Struct Dyn"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"15208","DOI":"10.3390\/ijms242015208","volume":"24","author":"Alsharairi N.A.","year":"2023","unstructured":"Alsharairi N.A.; Quercetin derivatives as potential therapeutic agents: An updated perspective on the treatment of nicotine-induced non-small cell lung cancer. Int J Mol Sci  2023,24(20),15208","journal-title":"Int J Mol Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5306\/wjco.v7.i2.189","volume":"7","author":"Orfali G.C.","year":"2016","unstructured":"Orfali G.C.; Duarte A.C.; Bonadio V.; Martinez N.P.; de Ara\u00fajo M.E.M.B.; Priviero F.B.M.; Carvalho P.O.; Priolli D.G.; Review of anticancer mechanisms of isoquercitin. World J Clin Oncol  2016,7(2),189-199","journal-title":"World J Clin Oncol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1073\/pnas.93.7.2735","volume":"93","author":"De Azevedo W.F.","year":"1996","unstructured":"De Azevedo W.F.; Mueller-Dieckmann H.J.; Schulze-Gahmen U.; Worland P.J.; Sausville E.; Kim S.H.; Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc Natl Acad Sci USA  1996,93(7),2735-2740","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.3390\/ijms22062935","volume":"22","author":"\u0141ukasik P.","year":"2021","unstructured":"\u0141ukasik P.; Za\u0142uski M.; Gutowska I.; Cyclin-dependent kinases (CDK) and their role in diseases development-review. Int J Mol Sci  2021,22(6),2935","journal-title":"Int J Mol Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3389\/fphar.2020.01230","volume":"11","author":"Cassandri M.","year":"2020","unstructured":"Cassandri M.; Fioravanti R.; Pomella S.; Valente S.; Rotili D.; Del Baldo G.; De Angelis B.; Rota R.; Mai A.; CDK9 as a valuable target in cancer: From natural compounds inhibitors to current treatment in pediatric soft tissue sarcomas. Front Pharmacol  2020,11,1230","journal-title":"Front Pharmacol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"678559","DOI":"10.3389\/fonc.2021.678559","volume":"11","author":"Anshabo A.T.","year":"2021","unstructured":"Anshabo A.T.; Milne R.; Wang S.; Albrecht H.; CDK9: A comprehensive review of its biology, and its role as a potential target for anti-cancer agents. Front Oncol  2021,11,678559","journal-title":"Front Oncol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0022-5347(01)67517-7","volume":"153","author":"Uchida T.","year":"1995","unstructured":"Uchida T.; Wada C.; Ishida H.; Wang C.; Egawa S.; Yoko-yama E.; Kameya T.; Koshiba K.; p53 mutations and prognosis in bladder tumors. J Urol  1995,153(4),1097-1104","journal-title":"J Urol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"109508","DOI":"10.1016\/j.cellsig.2019.109508","volume":"67","author":"Wu J.","year":"2020","unstructured":"Wu J.; Liang Y.; Tan Y.; Tang Y.; Song H.; Wang Z.; Li Y.; Lu M.; CDK9 inhibitors reactivate p53 by downregulating iASPP. Cell Signal  2020,67,109508","journal-title":"Cell Signal"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41401-021-00708-2","volume":"43","author":"Yao J.","year":"2021","unstructured":"Yao J.; Novel CDK9 inhibitor oroxylin a promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling. Acta Pharmacol Sin  2021,43(4),1033-1045","journal-title":"Acta Pharmacol Sin"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"E66","DOI":"10.1017\/S0029665112001231","volume":"71","author":"De Ferrars R.","year":"2012","unstructured":"De Ferrars R.; Cassidy A.; Curtis P.; Czank C.; Zhang Q.; Kalowole K.; Botting N.; Kay C.D.; Investigating the bioa-vailability of anthocyanin metabolites. Proc Nutr Soc  2012,71,E66","journal-title":"Proc Nutr Soc"},{"key":"ref=30","doi-asserted-by":"publisher","DOI":"10.1177\/1934578X231170221","volume":"18","author":"Moriwaki M.","year":"2023","unstructured":"Moriwaki M.; Tominaga E.; Kito K.; Nakagawa R.; Kapoor M.P.; Matsumiya Y.; Fukuhara T.; Kobayashi J.; Satomoto K.; Yamagata H.; Kuroiwa Y.; Bioavailability of flavonoids in ginkgo biloba extract-\u03b3-cyclodextrin complex. Nat Prod Commun  2023,18(5)","journal-title":"Nat Prod Commun"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/ejcn.2010.6","volume":"64","author":"Krogholm K.S.","year":"2010","unstructured":"Krogholm K.S.; Bredsdorff L.; Knuthsen P.; Haraldsd\u00f3ttir J.; Rasmussen S.E.; Relative bioavailability of the flavonoids quercetin, hesperetin and naringenin given simultaneously through diet. Eur J Clin Nutr  2010,64(4),432-435","journal-title":"Eur J Clin Nutr"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1021\/acs.molpharmaceut.7b00545","volume":"14","author":"Hu M.","year":"2017","unstructured":"Hu M.; Wu B.; Liu Z.; Bioavailability of polyphenols and flavonoids in the era of precision medicine. Mol Pharm  2017,14(9),2861-2863","journal-title":"Mol Pharm"},{"key":"ref=33","author":"Gohlke A.","year":"2015","unstructured":"Gohlke A.; Bioavailability of flavonoids after intraduodenal administration and their effects on the carbohydrate metabolism of dairy cows, exemplified by quercetin and its glucorhamnoside rutin. PhD Thesis  2015","journal-title":"PhD Thesis"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tifs.2020.10.030","volume":"117","author":"Kamiloglu S.","year":"2021","unstructured":"Kamiloglu S.; Tomas M.; Ozdal T.; Capanoglu E.; Effect of food matrix on the content and bioavailability of flavonoids. Trends Food Sci Technol  2021,117,15-33","journal-title":"Trends Food Sci Technol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/03602532.2014.1003649","volume":"47","author":"Gonzales G.B.","year":"2015","unstructured":"Gonzales G.B.; Smagghe G.; Grootaert C.; Zotti M.; Raes K.; Camp J.V.; Flavonoid interactions during digestion, absorption, distribution and metabolism: A sequential structure-activity\/property relationship-based approach in the study of bioavailability and bioactivity. Drug Metab Rev  2015,47(2),175-190","journal-title":"Drug Metab Rev"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.foodchem.2013.03.048","volume":"141","author":"\u015awieca M.","year":"2013","unstructured":"\u015awieca M.; Gawlik-Dziki U.; Dziki D.; Baraniak B.; Czy\u017c J.; The influence of protein-flavonoid interactions on protein digestibility in vitro and the antioxidant quality of breads enriched with onion skin. Food Chem  2013,141(1),451-458","journal-title":"Food Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0753-3322(97)88045-6","volume":"51","author":"Hollman P.C.H.","year":"1997","unstructured":"Hollman P.C.H.; Katan M.B.; Absorption, metabolism and health effects of dietary flavonoids in man. Biomed Pharmacother  1997,51(8),305-310","journal-title":"Biomed Pharmacother"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2174\/1389200216666150206123719","volume":"15","author":"Ma Y.","year":"2015","unstructured":"Ma Y.; Zeng M.; Sun R.; Hu M.; Disposition of flavonoids impacts their efficacy and safety. Curr Drug Metab  2015,15(9),841-864","journal-title":"Curr Drug Metab"},{"key":"ref=39","first-page":"3231","volume":"30","author":"Sun X.","year":"2015","unstructured":"Sun X.; Research progress in influence factors of flavonoids compounds bioavailability. China J Tradit Chin Med Pharmacy  2015,30(9),3231-3233","journal-title":"China J Tradit Chin Med Pharmacy"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/nure.12114","volume":"72","author":"Bohn T.","year":"2014","unstructured":"Bohn T.; Dietary factors affecting polyphenol bioavailability. Nutr Rev  2014,72(7),429-452","journal-title":"Nutr Rev"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/1541-4337.12342","volume":"17","author":"Almeida A.F.","year":"2018","unstructured":"Almeida A.F.; Borge G.I.A.; Piskula M.; Tudose A.; Tudoreanu L.; Valentov\u00e1 K.; Williamson G.; Santos C.N.; Bio-availability of quercetin in humans with a focus on interindividual variation. Compr Rev Food Sci Food Saf  2018,17(3),714-731","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/bioengineering9050197","volume":"9","author":"Ferreira M.","year":"2022","unstructured":"Ferreira M.; Costa D.; Sousa \u00c2.; Flavonoids-based delivery systems towards cancer therapies. Bioengineering  2022,9(5),197","journal-title":"Bioengineering"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1021\/acs.jafc.5b01495","volume":"63","author":"Ban C.","year":"2015","unstructured":"Ban C.; Park S.J.; Lim S.; Choi S.J.; Choi Y.J.; Improving flavonoid bioaccessibility using an edible oil-based lipid nanoparticle for oral delivery. J Agric Food Chem  2015,63(21),5266-5272","journal-title":"J Agric Food Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3109\/03639045.2014.991402","volume":"41","author":"Wang H.","year":"2015","unstructured":"Wang H.; Cui Y.; Fu Q.; Deng B.; Li G.; Yang J.; Wu T.; Xie Y.; A phospholipid complex to improve the oral bioavailability of flavonoids. Drug Dev Ind Pharm  2015,41(10),1693-1703","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.3390\/molecules25143254","volume":"25","author":"Micale N.","year":"2020","unstructured":"Micale N.; Citarella A.; Molonia M.S.; Speciale A.; Cimino F.; Saija A.; Cristani M.; Hydrogels for the delivery of plant-derived (poly)phenols. Molecules  2020,25(14),3254","journal-title":"Molecules"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.tifs.2021.11.032","volume":"119","author":"Kandemir K.","year":"2022","unstructured":"Kandemir K.; Tomas M.; McClements D.J.; Capanoglu E.; Recent advances on the improvement of quercetin bioavailability. Trends Food Sci Technol  2022,119,192-200","journal-title":"Trends Food Sci Technol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.3390\/foods10112701","volume":"10","author":"Ayala-Fuentes J.C.","year":"2021","unstructured":"Ayala-Fuentes J.C.; Chavez-Santoscoy R.A.; Nanotechnology as a key to enhance the benefits and improve the bioavailability of flavonoids in the food industry. Foods  2021,10(11),2701","journal-title":"Foods"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1248\/bpb.b15-00854","volume":"39","author":"Guan Q.","year":"2016","unstructured":"Guan Q.; Zhang G.; Sun S.; Fan H.; Sun C.; Zhang S.; Enhanced oral bioavailability of pueraria flavones by a novel solid selfmicroemulsifying drug delivery system (SMEDDS) dropping pills. Biol Pharm Bull  2016,39(5),762-769","journal-title":"Biol Pharm Bull"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1021\/jf00032a015","volume":"41","author":"Hertog M.G.L.","year":"1993","unstructured":"Hertog M.G.L.; Hollman P.C.H.; van de Putte B.; Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. J Agric Food Chem  1993,41(8),1242-1246","journal-title":"J Agric Food Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.phytochem.2017.09.016","volume":"145","author":"Mani R.","year":"2018","unstructured":"Mani R.; Natesan V.; Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action. Phytochemistry  2018,145,187-196","journal-title":"Phytochemistry"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/BF02465832","volume":"32","author":"Andreeva O.A.","year":"1998","unstructured":"Andreeva O.A.; Ivashev M.N.; Ozimina I.I.; Maslikova G.V.; Diosmetin glycosides from Caucasian vetch: Isolation and study of biological activity. Pharm Chem J  1998,32(11),595-597","journal-title":"Pharm Chem J"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"100179","DOI":"10.1016\/j.phyplu.2021.100179","volume":"2","author":"Garg M.","year":"2022","unstructured":"Garg M.; Chaudhary S.K.; Goyal A.; Sarup P.; Kumari S.; Garg N.; Vaid L.; Shiveena B.; Comprehensive review on therapeutic and phytochemical exploration of diosmetin: A promising moiety. Phytomedicine Plus  2022,2(1),100179","journal-title":"Phytomedicine Plus"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"e105070","DOI":"10.1371\/journal.pone.0105070","volume":"9","author":"Sahu B.D.","year":"2014","unstructured":"Sahu B.D.; Kalvala A.K.; Koneru M.; Mahesh Kumar J.; Kuncha M.; Rachamalla S.S.; Sistla R.; Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-\u03baB activation and antioxidant defence. PLoS One  2014,9(9),e105070","journal-title":"PLoS One"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3945\/an.116.012948","volume":"8","author":"Hostetler G.L.","year":"2017","unstructured":"Hostetler G.L.; Ralston R.A.; Schwartz S.J.; Flavones: Food sources, bioavailability, metabolism, and bioactivity. Adv Nutr  2017,8(3),423-435","journal-title":"Adv Nutr"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ejmech.2014.07.013","volume":"84","author":"Singh M.","year":"2014","unstructured":"Singh M.; Kaur M.; Silakari O.; Flavones: An important scaffold for medicinal chemistry. Eur J Med Chem  2014,84,206-239","journal-title":"Eur J Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"118395","DOI":"10.1016\/j.lfs.2020.118395","volume":"259","author":"Liu K.","year":"2020","unstructured":"Liu K.; Zhao F.; Yan J.; Xia Z.; Jiang D.; Ma P.; Hispidulin: A promising flavonoid with diverse anti-cancer properties. Life Sci  2020,259,118395","journal-title":"Life Sci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00764-023-00267-8","volume":"37","author":"Rout K.K.","year":"2024","unstructured":"Rout K.K.; Kar M.K.; Agarwal P.C.; Dash S.K.; Analysis of bioactive hispidulin: An anticancer flavone of Clerodendrum philippinum. J Planar Chromatogr Mod TLC  2024,37(1),49-56","journal-title":"J Planar Chromatogr Mod TLC"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"298","DOI":"10.2174\/138955711795305335","volume":"11","author":"Calder\u00f3n-Monta\u00f1o J.M.","year":"2011","unstructured":"Calder\u00f3n-Monta\u00f1o J.M.; Burgos-Mor\u00f3n E.; P\u00e9rez-Guerrero C.; L\u00f3pez-L\u00e1zaro M.; A review on the dietary flavonoid kaempferol. Mini Rev Med Chem  2011,11(4),298-344","journal-title":"Mini Rev Med Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"384S","DOI":"10.3945\/an.112.003517","volume":"4","author":"Liu R.H.","year":"2013","unstructured":"Liu R.H.; Health-promoting components of fruits and vegetables in the diet. Adv Nutr  2013,4(3),384S-392S","journal-title":"Adv Nutr"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5487\/TR.2013.29.4.229","volume":"29","author":"Kim S.H.","year":"2013","unstructured":"Kim S.H.; Choi K.C.; Anti-cancer effect and underlying mechanism(s) of kaempferol, a phytoestrogen, on the regulation of apoptosis in diverse cancer cell models. Toxicol Res  2013,29(4),229-234","journal-title":"Toxicol Res"},{"key":"ref=61","author":"Manzoor M.F.","year":"2000","unstructured":"Manzoor M.F.; Ahmad N.;  Food Based Phytochemical Luteolin Their Derivatives  2000","journal-title":"Food Based Phytochemical Luteolin Their Derivatives"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/138955709787001712","volume":"9","author":"L\u00f3pez-L\u00e1zaro M.","year":"2009","unstructured":"L\u00f3pez-L\u00e1zaro M.; Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem  2009,9(1),31-59","journal-title":"Mini Rev Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"108612","DOI":"10.1016\/j.biopha.2019.108612","volume":"112","author":"Imran M.","year":"2019","unstructured":"Imran M.; Rauf A.; Abu-Izneid T.; Nadeem M.; Shariati M.A.; Khan I.A.; Imran A.; Orhan I.E.; Rizwan M.; Atif M.; Gondal T.A.; Mubarak M.S.; Luteolin, a flavonoid, as an anticancer agent: A review. Biomed Pharmacother  2019,112,108612","journal-title":"Biomed Pharmacother"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0308-8146(01)00114-5","volume":"73","author":"Justesen U.","year":"2001","unstructured":"Justesen U.; Knuthsen P.; Composition of flavonoids in fresh herbs and calculation of flavonoid intake by use of herbs in traditional Danish dishes. Food Chem  2001,73(2),245-250","journal-title":"Food Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1021\/jf000070p","volume":"48","author":"Stewart A.J.","year":"2000","unstructured":"Stewart A.J.; Bozonnet S.; Mullen W.; Jenkins G.I.; Lean M.E.J.; Crozier A.; Occurrence of flavonols in tomatoes and tomato-based products. J Agric Food Chem  2000,48(7),2663-2669","journal-title":"J Agric Food Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1021\/jf010697n","volume":"49","author":"Zheng W.","year":"2001","unstructured":"Zheng W.; Wang S.Y.; Antioxidant activity and phenolic compounds in selected herbs. J Agric Food Chem  2001,49(11),5165-5170","journal-title":"J Agric Food Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"Kim S.","year":"2023","unstructured":"Kim S.; Chen J.; Cheng T.; Gindulyte A.; He J.; He S.; Li Q.; Shoemaker B.A.; Thiessen P.A.; Yu B.; Zaslavsky L.; Zhang J.; Bolton E.E.; PubChem 2023 update. Nucleic Acids Res  2023,51(D1),D1373-D1380","journal-title":"Nucleic Acids Res"},{"key":"ref=68","author":"Jeremy Appleton N.D.","unstructured":"Jeremy Appleton N.D.; Evaluating the bioavailability of isoquercetin. Nat Med J","journal-title":"Nat Med J"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"Berman H.M.","year":"2000","unstructured":"Berman H.M.; Westbrook J.; Feng Z.; Gilliland G.; Bhat T.N.; Weissig H.; Shindyalov I.N.; Bourne P.E.; The protein data bank. Nucleic Acids Res  2000,28(1),235-242","journal-title":"Nucleic Acids Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1758-2946-1-15","volume":"1","author":"Bikadi Z.","year":"2009","unstructured":"Bikadi Z.; Hazai E.; Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. J Cheminform  2009,1(1),15","journal-title":"J Cheminform"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"e187410452305170","DOI":"10.2174\/18741045-v17-230619-2023-7","volume":"17","author":"Sony A.S.","year":"2023","unstructured":"Sony A.S.; Suresh X.; Molecular docking-based screening of natural heterocyclic compounds as a potential drug for COVID-19. Open Med Chem J  2023,17(1),e187410452305170","journal-title":"Open Med Chem J"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/jcc.20634","volume":"28","author":"Huey R.","year":"2007","unstructured":"Huey R.; Morris G.M.; Olson A.J.; Goodsell D.S.; A semiempirical free energy force field with charge\u2010based desolvation. J Comput Chem  2007,28(6),1145-1152","journal-title":"J Comput Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"Morris G.M.","year":"2009","unstructured":"Morris G.M.; Huey R.; Lindstrom W.; Sanner M.F.; Belew R.K.; Goodsell D.S.; Olson A.J.; AutoDock4 and AutoDock-Tools4: Automated docking with selective receptor flexibility. J Comput Chem  2009,30(16),2785-2791","journal-title":"J Comput Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1-2","author":"Abraham M.J.","year":"2015","unstructured":"Abraham M.J.; Murtola T.; Schulz R.; P\u00e1ll S.; Smith J.C.; Hess B.; Lindahl E.; GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX  2015,1-2,19-25","journal-title":"SoftwareX"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1021\/ct200196m","volume":"7","author":"Malde A.K.","year":"2011","unstructured":"Malde A.K.; Zuo L.; Breeze M.; Stroet M.; Poger D.; Nair P.C.; Oostenbrink C.; Mark A.E.; An automated force field topology builder (ATB) and repository: Version 1.0. J Chem Theory Comput  2011,7(12),4026-4037","journal-title":"J Chem Theory Comput"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1080\/07391102.2019.1667265","volume":"38","author":"Gangadharappa B.S.","year":"2020","unstructured":"Gangadharappa B.S.; Sharath R.; Revanasiddappa P.D.; Chandramohan V.; Balasubramaniam M.; Vardhineni T.P.; Structural insights of metallo-beta-lactamase revealed an effective way of inhibition of enzyme by natural inhibitors. J Biomol Struct Dyn  2020,38(13),3757-3771","journal-title":"J Biomol Struct Dyn"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.4155\/fmc.12.149","volume":"4","author":"Gago F.","year":"2012","unstructured":"Gago F.; Molecular simulations of drug-receptor complexes in anticancer research. Future Med Chem  2012,4(15),1961-1970","journal-title":"Future Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.2174\/0115680266250924230920042845","volume":"23","author":"Dewaker V.","year":"2023","unstructured":"Dewaker V.; Prabhakar Y.S.; Molecular dynamics simulations of HDAC-ligand complexes towards the design of new anticancer compounds. Curr Top Med Chem  2023,23(29),2743-2764","journal-title":"Curr Top Med Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"105243","DOI":"10.1016\/j.dib.2020.105243","volume":"29","author":"Moulishankar A.","year":"2020","unstructured":"Moulishankar A.; Lakshmanan K.; Data on molecular docking of naturally occurring flavonoids with biologically important targets. Data Brief  2020,29,105243","journal-title":"Data Brief"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/B978-0-444-64179-3.00012-8","volume":"59","author":"Patil V.M.","year":"2018","unstructured":"Patil V.M.; Masand N.; Anticancer potential of flavonoids: Chemistry, biological activities, and future perspectives. Stud Nat Prod Chem  2018,59,401-430","journal-title":"Stud Nat Prod Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"100010","DOI":"10.1016\/j.ejmcr.2021.100010","volume":"3","author":"Khan A.U.","year":"2021","unstructured":"Khan A.U.; Dagur H.S.; Khan M.; Malik N.; Alam M.; Mushtaque M.; Therapeutic role of flavonoids and flavones in cancer prevention: Current trends and future perspectives. Eur J Med Chem Rep  2021,3,100010","journal-title":"Eur J Med Chem Rep"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1002\/jcb.30465","volume":"124","author":"Singothu S.","year":"2023","unstructured":"Singothu S.; Begum P.J.; Maddi D.; Devsani N.; Bhandari V.; Unveiling the potential of marine compounds as quorum sensing inhibitors targeting Pseudomonas aeruginosa 's LasI: A computational study using molecular docking and molecular dynamics. J Cell Biochem  2023,124(10),1573-1586","journal-title":"J Cell Biochem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"133785","DOI":"10.1016\/j.molstruc.2022.133785","volume":"1269","author":"Raja G.","year":"2022","unstructured":"Raja G.; Venkatesh G.; Al-Otaibi J.S.; Vennila P.; Mary Y.S.; Sixto-L\u00f3pez Y.; Synthesis, characterization, molecular docking and molecular dynamics simulations of benzamide derivatives as potential anti-ovarian cancer agents. J Mol Struct  2022,1269,133785","journal-title":"J Mol Struct"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.electacta.2015.02.164","volume":"163","author":"Ferreira R.Q.","year":"2015","unstructured":"Ferreira R.Q.; Greco S.J.; Delarmelina M.; Weber K.C.; Electrochemical quantification of the structure\/antioxidant activity relationship of flavonoids. Electrochim Acta  2015,163,161-166","journal-title":"Electrochim Acta"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.3390\/cancers13092181","volume":"13","author":"Mandal R.","year":"2021","unstructured":"Mandal R.; Becker S.; Strebhardt K.; Targeting CDK9 for anti-cancer therapeutics. Cancers  2021,13(9),2181","journal-title":"Cancers"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41589-021-00742-5","volume":"17","author":"Wang L.","year":"2021","unstructured":"Wang L.; Shao X.; Zhong T.; Wu Y.; Xu A.; Sun X.; Gao H.; Liu Y.; Lan T.; Tong Y.; Tao X.; Du W.; Wang W.; Chen Y.; Li T.; Meng X.; Deng H.; Yang B.; He Q.; Ying M.; Rao Y.; Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy. Nat Chem Biol  2021,17(5),567-575","journal-title":"Nat Chem Biol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.drudis.2019.12.001","volume":"25","author":"Tadesse S.","year":"2020","unstructured":"Tadesse S.; Anshabo A.T.; Portman N.; Lim E.; Tilley W.; Caldon C.E.; Wang S.; Targeting CDK2 in cancer: Challenges and opportunities for therapy. Drug Discov Today  2020,25(2),406-413","journal-title":"Drug Discov Today"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064314933240812120123","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/233497\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064314933240812120123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T07:05:01Z","timestamp":1733727901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/233497\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734064314933240812120123","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-04-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}